| # | Drug | Count |
|---|---|---|
| 0 | CLARITHROMYCIN | 2 |
| 1 | ACETAMINOPHEN | 1 |
| 2 | ACETAMINOPHEN 500MG | 1 |
| 3 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 4 | ADALIMUMAB | 1 |
| 5 | ALEMTUZUMAB | 1 |
| 6 | ATORVASTATIN CALCIUM | 1 |
| 7 | CARBOPLATIN | 1 |
| 8 | CYCLOPHOSPHAMIDE | 1 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VINBLASTINE SULFATE | 1 | 0.0005 |
| 1 | TOPOTECAN HYDROCHLORIDE | 1 | 0.0004 |
| 2 | HUMAN INSULIN | 1 | 0.0001 |
| 3 | THIOTEPA | 1 | 0.0001 |
| 4 | IRINOTECAN HYDROCHLORIDE | 1 | 0.0001 |
| 5 | CLARITHROMYCIN | 2 | 0.0001 |
| 6 | ALEMTUZUMAB | 1 | 0.0001 |
| 7 | IFOSFAMIDE FOR INJECTION | 1 | 0.0000 |
| 8 | MELPHALAN HYDROCHLORIDE | 1 | 0.0000 |
| 9 | VINCRISTINE SULFATE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 1 | Macrolide Antimicrobial [EPC] | 2 | 0.0000 |
| 2 | Insulin [EPC] | 1 | 0.0000 |
| 3 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3 | 0.0000 |
| 9 | Insulin Analog [EPC] | 1 | 0.0000 |